Patrick Flavin became director of industry and strategy at Outcome Health, a health information provider, in January 2016. He is also a principal at Flavin Ventures. Before taking the position with Outcome Health — then ContextMedia — he served as executive director of partnerships at health-tech incubator Matter.
Outcome Health, founded in 2006 by Rishi Shah and Shradha Agarwal, distributes condition-specific health programming at doctors’ offices and at other points of care. Last year, the company announced plans to add 600 jobs by the end of 2016.
Flavin was named to the post at Matter, a co-working space for medical device, biopharma and information technology startups, in 2014 and will remain as an adviser.
Previously, Flavin was the chief legal counsel for Advanced Life Sciences Holdings, a Woodridge-based biopharmaceutical company.
Flavin’s entrepreneurial background has roots in his family. Growing up as the youngest of nine siblings, “You had to speak up loudly to be heard, and if you wanted to eat, you had to fight,” Flavin told Blue Sky. “By the time I came around, I had to rely on my siblings. We all learned to work as a team.”
Along with his brothers John and Michael, he runs Flavin Ventures, an early-stage technology fund whose portfolio includes pharma-tech companies like Altathera Pharmaceuticals, Cell Habitats and Shamrock Structures.
“You have a situation in Chicago with a growing and evolving biotech ecology, and you have three brothers who have pushed to the front of the line, so to speak, in a humble and dignified way,” said Scott Meadow, a private-equity professional and professor of entrepreneurship at the University of Chicago Booth School of Business.
Flavin received his Bachelor’s Degree from Providence College in Providence, R.I., and his J.D. from DePaul University College of Law.